July 27, 2006
: Health Canada "Categorized In" Substances
| ID | CAS RN | Chemical Name | Maximal List Subgroup | Status | SimHaz Result Carcinogenicity1 |
SimHaz Result Developmental Toxicity2 |
SimHaz Result Genotoxicity3 |
SimHaz Result Reproductive Toxicity4 |
|---|---|---|---|---|---|---|---|---|
| 1 | 62-56-6 | Thiourea | High - GPE | GPE | X | X | ||
| 2 | 74-87-3 | Methane, chloro- | High - GPE | GPE | X | |||
| 3 | 75-28-5 | Propane, 2-methyl- | High - GPE | GPE | X | X | ||
| 4 | 75-56-9 | Oxirane, methyl- | High - GPE | GPE | X | X | ||
| 5 | 78-59-1 | 2-Cyclohexen-1-one, 3,5,5-trimethyl- | High - GPE | GPE | X | |||
| 6 | 78-79-5 | 1,3-Butadiene, 2-methyl- | High - GPE | GPE | X | X | ||
| 7 | 79-06-1 | 2-Propenamide | High - GPE | GPE | X | X | X | |
| 8 | 80-05-7 | Phenol, 4,4 -(1-methylethylidene)bis- | High - GPE | GPE | X | |||
| 9 | 91-20-3 | Naphthalene | High - GPE | GPE | X | |||
| 10 | 96-29-7 | 2-Butanone, oxime | High - GPE | GPE | X | |||
| 11 | 98-01-1 | 2-Furancarboxaldehyde | High - GPE | GPE | X | |||
| 12 | 100-41-4 | Benzene, ethyl- | High - GPE | GPE | X | |||
| 13 | 100-44-7 | Benzene, (chloromethyl)- | High - GPE | GPE | X | |||
| 14 | 103-23-1 | Hexanedioic acid, bis(2-ethylhexyl) ester | High - GPE | GPE | X | |||
| 15 | 106-89-8 | Oxirane, (chloromethyl)- | High - GPE | GPE | X | |||
| 16 | 106-97-8 | Butane | High - GPE | GPE | X | X | ||
| 17 | 108-05-4 | Acetic acid ethenyl ester | High - GPE | GPE | X | |||
| 18 | 110-54-3 | Hexane | High - GPE | GPE | X | X | ||
| 19 | 111-15-9 | Ethanol, 2-ethoxy-, acetate | High - GPE | GPE | X | X | ||
| 20 | 111-77-3 | Ethanol, 2-(2-methoxyethoxy)- | High - GPE | GPE | X | |||
| 21 | 123-31-9 | 1,4-Benzenediol | High - GPE | GPE | X | X | ||
| 22 | 123-91-1 | 1,4-Dioxane | High - GPE | GPE | X | |||
| 23 | 140-88-5 | 2-Propenoic acid, ethyl ester | High - GPE | GPE | X | |||
| 24 | 149-57-5 | Hexanoic acid, 2-ethyl- | High - GPE | GPE | X | |||
| 25 | 630-08-0 | Carbon monoxide | High - GPE | GPE | X | |||
| 26 | 1309-64-4 | Antimony oxide (Sb2O3) | High - GPE | GPE | X | |||
| 27 | 1314-62-1 | Vanadium oxide (V2O5) | High - GPE | GPE | X | X | X | |
| 28 | 1333-86-4 | Carbon black | High - GPE | GPE | X | |||
| 29 | 1344-37-2 | C.I. Pigment Yellow 34 | High - GPE | GPE | X | X | X | |
| 30 | 7440-48-4 | Cobalt | High - GPE | GPE | X | |||
| 31 | 10124-43-3 | Sulfuric acid, cobalt(2+) salt (1:1) | High - GPE | GPE | X | |||
| 32 | 12656-85-8 | C.I. Pigment Red 104 | High - GPE | GPE | X | X | X | |
| 33 | 14464-46-1 | Cristobalite (SiO2) | High - GPE | GPE | X | |||
| 34 | 14808-60-7 | Quartz (SiO2) | High - GPE | GPE | X | |||
| 35 | 26471-62-5 | Benzene, 1,3-diisocyanatomethyl- | High - GPE | GPE | X | |||
| 36 | 68391-11-7 | Pyridine, alkyl derivs. | High - GPE | GPE | X | |||
| 37 | 64-67-5 | Sulfuric acid, diethyl ester | High - IPE | IThuman + P or B | X | X | ||
| 38 | 75-12-7 | Formamide | High - IPE | Other High Health Priority | X | |||
| 39 | 75-52-5 | Methane, nitro- | High - IPE | IThuman + P or B | X | |||
| 40 | 77-78-1 | Sulfuric acid, dimethyl ester | High - IPE | Other High Health Priority | X | X | ||
| 41 | 79-07-2 | Acetamide, 2-chloro- | High - IPE | Other High Health Priority | X | |||
| 42 | 79-46-9 | Propane, 2-nitro- | High - IPE | IThuman + P or B | X | |||
| 43 | 87-86-5 | Phenol, pentachloro- | High - IPE | IThuman + P or B | X | |||
| 44 | 88-12-0 | 2-Pyrrolidinone, 1-ethenyl- | High - IPE | Other High Health Priority | X | |||
| 45 | 88-72-2 | Benzene, 1-methyl-2-nitro- | High - IPE | IThuman + P or B | X | X | X | X |
| 46 | 90-94-8 | Methanone, bis[4-(dimethylamino)phenyl]- | High - IPE | IThuman + P or B | X | X | ||
| 47 | 91-08-7 | Benzene, 1,3-diisocyanato-2-methyl- | High - IPE | Other High Health Priority | X | |||
| 48 | 93-15-2 | Benzene, 1,2-dimethoxy-4-(2-propenyl)- | High - IPE | Other High Health Priority | X | |||
| 49 | 101-14-4 | Benzenamine, 4,4'-methylenebis[2-chloro- | High - IPE | IThuman + P or B | X | |||
| 50 | 102-06-7 | Guanidine, N,N -diphenyl- | High - IPE | IThuman + P or B | X | X | ||
| 51 | 106-88-7 | Oxirane, ethyl- | High - IPE | IThuman + P or B | X | |||
| 52 | 106-93-4 | Ethane, 1,2-dibromo- | High - IPE | IThuman + P or B | X | |||
| 53 | 107-05-1 | 1-Propene, 3-chloro- | High - IPE | Other High Health Priority | X | X | ||
| 54 | 107-22-2 | Ethanedial | High - IPE | Other High Health Priority | X | |||
| 55 | 110-49-6 | Ethanol, 2-methoxy-, acetate | High - IPE | Other High Health Priority | X | X | ||
| 56 | 115-96-8 | Ethanol, 2-chloro-, phosphate (3:1) | High - IPE | IThuman + P or B | X | |||
| 57 | 117-82-8 | 1,2-Benzenedicarboxylic acid, bis(2-methoxyethyl) ester | High - IPE | Other High Health Priority | X | X | ||
| 58 | 120-80-9 | 1,2-Benzenediol | High - IPE | Other High Health Priority | X | |||
| 59 | 126-73-8 | Phosphoric acid tributyl ester | High - IPE | IThuman + P or B | X | |||
| 60 | 127-19-5 | Acetamide, N,N-dimethyl- | High - IPE | Other High Health Priority | X | |||
| 61 | 139-13-9 | Glycine, N,N-bis(carboxymethyl)- | High - IPE | IThuman + P or B | X | |||
| 62 | 302-01-2 | Hydrazine | High - IPE | Other High Health Priority | X | |||
| 63 | 330-54-1 | Urea, N'-(3,4-dichlorophenyl)-N,N-dimethyl- | High - IPE | IThuman + P or B | X | |||
| 64 | 534-52-1 | Phenol, 2-methyl-4,6-dinitro- | High - IPE | IThuman + P or B | X | |||
| 65 | 556-67-2 | Cyclotetrasiloxane, octamethyl- | High - IPE | IThuman + P or B | X | X | ||
| 66 | 584-84-9 | Benzene, 2,4-diisocyanato-1-methyl- | High - IPE | Other High Health Priority | X | |||
| 67 | 1589-47-5 | 1-Propanol, 2-methoxy- | High - IPE | Other High Health Priority | X | |||
| 68 | 2426-08-6 | Oxirane, (butoxymethyl)- | High - IPE | Other High Health Priority | X | X | ||
| 69 | 7646-79-9 | Cobalt chloride (CoCl2) | High - IPE | IThuman + P or B | X | |||
| 70 | 7758-01-2 | Bromic acid, potassium salt | High - IPE | IThuman + P or B | X | |||
| 71 | 25013-16-5 | Phenol, (1,1-dimethylethyl)-4-methoxy- | High - IPE | Other High Health Priority | X | |||
| 72 | 68515-42-4 | 1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters | High - IPE | Other High Health Priority | X | X | ||
| 73 | 50-18-0 | 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-,2-oxide | High - FDA | Other High Health Priority | X | |||
| 74 | 55-86-7 | Ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl-, hydrochloride | High - FDA | Other High Health Priority | X | |||
| 75 | 55-98-1 | 1,4-Butanediol, dimethanesulfonate | High - FDA | Other High Health Priority | X | |||
| 76 | 57-41-0 | 2,4-Imidazolidinedione, 5,5-diphenyl- | High - FDA | Other High Health Priority | X | |||
| 77 | 68-22-4 | 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17αa)- | High - FDA | Other High Health Priority | X | |||
| 78 | 126-07-8 | Spiro[benzofuran-2(3H),1'-[2]cyclohexene]-3,4'-dione, 7-chloro-2',4,6-trimethoxy-6'-methyl-, (1'S,6'R)- | High - FDA | Other High Health Priority | X | |||
| 79 | 148-82-3 | L-Phenylalanine, 4-[bis(2-chloroethyl)amino]- | High - FDA | Other High Health Priority | X | |||
| 80 | 154-93-8 | Urea, N,N'-bis(2-chloroethyl)-N-nitroso- | High - FDA | Other High Health Priority | X | |||
| 81 | 305-03-3 | Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]- | High - FDA | Other High Health Priority | X | |||
| 82 | 443-48-1 | 1H-Imidazole-1-ethanol, 2-methyl-5-nitro- | High - FDA | Other High Health Priority | X | |||
| 83 | 446-86-6 | 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- | High - FDA | Other High Health Priority | X | |||
| 84 | 6804-07-5 | Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-, methyl ester | High - FDA | Other High Health Priority | X | |||
| 85 | 7446-34-6 | Selenium sulfide | High - FDA | IThuman + P or B | X | |||
| 86 | 10540-29-1 | Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl- | High - FDA | IThuman + P or B | X | |||
| 87 | 13010-47-4 | Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso- | High - FDA | Other High Health Priority | X | |||
| 88 | 18883-66-4 | D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]- | High - FDA | Other High Health Priority | X | |||
| 89 | 20830-81-3 | D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]- | High - FDA | Other High Health Priority | X | |||
| 90 | 29767-20-2 | Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-[[4,6-O-[(R)-2-thienylmethylene]-β-D-glucopyranosyl]oxy]-, (5R,5aR,8aR,9S)- | High - FDA | Other High Health Priority | X | |||
| 91 | 33419-42-0 | Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-α-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahy dro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, | High - FDA | Other High Health Priority | X | |||
| 92 | 51264-14-3 | Methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]- | High - FDA | Other High Health Priority | X | |||
| 93 | 59865-13-3 | Cyclosporin A | High - FDA | IThuman + P or B | X | |||
| 94 | 50-06-6 | 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl- | High - LPE | Other High Health Priority | X | |||
| 95 | 51-79-6 | Carbamic acid, ethyl ester | High - LPE | Other High Health Priority | X | |||
| 96 | 55-18-5 | Diethylnitrosamine | High - LPE | Other High Health Priority | X | |||
| 97 | 56-75-7 | Acetamide, 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R-(R*,R*)]- | High - LPE | Other High Health Priority | X | |||
| 98 | 58-89-9 | Cyclohexane, 1,2,3,4,5,6-hexachloro-, (1α,2α,3β,4α,5α,6β)- | High - LPE | IThuman + P or B | X | |||
| 99 | 59-88-1 | Hydrazine, phenyl-, monohydrochloride | High - LPE | Other High Health Priority | X | X | ||
| 100 | 60-09-3 | Benzenamine, 4-(phenylazo)- | High - LPE | Other High Health Priority | X |
B - bioaccumulation/bioaccumulative
CAS RN - Chemical Abstracts Registry Number
FDA - Food and Drugs Act substances in commerce in 1984-1986 which were added to the DSL
GPE - Greatest Potential for Exposure
IPE - Intermediate Potential for Exposure
IThuman - inherently toxic to humans
LPE - Lowest Potential for Exposure
P - persistence/persistent
SimHaz - Simple Hazard
Tool